Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of treatment outcomes for allergic rhinitis before and after accurate administration of steroid nasal spray
TCTR20211117001Not yet recruiting
- Sponsor
- HRH Princess Maha Chakri Sirindhorn Medical Center
- Start
- Jan 2022
- Countries
- 1
01
Overview
Trial in allergic rhinitis (AR) (2 arms), sponsored by HRH Princess Maha Chakri Sirindhorn Medical Center. Primary endpoints: Clinical symptom improvement and Overall treatment outcome. Planned start Jan 2022; status: not yet recruiting.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20211117001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211117001.